Stocks · News reference
US stock futures higher with Nasdaq 100 up 150 points. Ryanair (RYAAY) shares fall after weak Q1 results. Other stocks declining in pre-market.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Cytek Biosciences, Inc. ("Cytek Biosciences," "Cytek," or the "Company") (NASDAQ:CTKB), a leading cell analysis solutions company, today announced that a jury in the United States District Court
Filed: 2026-08-05 AccNo: 0001193125-26-335212 Size: 280 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 125 percent decrease over losses of $(0.04) per share from the same period last year.
Cytek Biosciences (NASDAQ:CTKB) raises FY2026 sales outlook from $205.000 million-$212.000 million to $207.000 million-$212.000 million vs $208.767 million estimate.
U.S. stock markets declined on August 31, 2026, as surging oil prices above $90 a barrel amid U.S.-Iran military tensions dampened investor risk appetite. The S&P 500 fell 0.33%, the Dow Jones dropped 0.70%, and the Nasdaq edged down 0.12%. Despite the daily decline, the S&P 500 finished August with a 2.6% gain. Energy stocks gained while basic materials and industrials saw the biggest losses. Investors remain cautious ahead of potential Federal Reserve rate hikes in September.
https://news.microsoft.com/source/asia/features/microsofts-newest-india-datacenter-region-goes-live-to-power-the-countrys-ai-economy-and-enable-frontier-firms/